Drug profile

The FDA adverse-event record for Bovine Rhinotracheitis + Virus Diarrhea + Parainfluenza + Respiratory Syncytial Virus Vaccine + Mannheimia Haemolytica Toxoid

10 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bovine Rhinotracheitis + Virus Diarrhea + Parainfluenza + Respiratory Syncytial Virus Vaccine + Mannheimia Haemolytica Toxoid. See the species affected, top reactions, and outcomes below.

10
adverse-event reports
60.0%
death-coded share
Cattle
most-reported species
6
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
6
Deaths Reported
60.0%
Death Rate

Active Ingredients

Bovine Rhinotracheitis + Virus Diarrhea + Parainfluenza + Respiratory Syncytial Virus Vaccine + Mannheimia Haemolytica Toxoid

Administration Routes

ParenteralUnknownSubcutaneous

Species Affected

Cattle 10

Most Affected Breeds

Crossbred Bovine/Cattle 3
Cattle (unknown) 3
Mixed (Cattle) 2
Jersey 1
Holstein-Friesian also known as Holstein 1

Most Reported Reactions

Death 6
Implant site bleeding 3
Lack of efficacy - NOS 3
Anaphylaxis 1
Partial anorexia 1
Milk drop 1
INEFFECTIVE, COCCIDIA 1
Recumbency 1
Necropsy performed 1

Outcome Breakdown

Died
6 (40.0%)
Outcome Unknown
6 (40.0%)
Ongoing
2 (13.3%)
Recovered/Normal
1 (6.7%)

Bovine Rhinotracheitis + Virus Diarrhea + Parainfluenza + Respiratory Syncytial Virus Vaccine + Mannheimia Haemolytica Toxoid Adverse Event Insights

10 reports name Bovine Rhinotracheitis + Virus Diarrhea + Parainfluenza + Respiratory Syncytial Virus Vaccine + Mannheimia Haemolytica Toxoid; 6 recorded a death outcome (60.0% of reported events, not a population-level mortality rate). Active ingredient: Bovine Rhinotracheitis + Virus Diarrhea + Parainfluenza + Respiratory Syncytial Virus Vaccine + Mannheimia Haemolytica Toxoid. Administration routes: Parenteral, Unknown, Subcutaneous.

By species: Cattle (10 reports). By breed: Crossbred Bovine/Cattle (3), Cattle (unknown) (3), Mixed (Cattle) (2).

Leading clinical signs: Death (6), Implant site bleeding (3), Lack of efficacy - NOS (3), Anaphylaxis (1). Outcome, 15 coded reports: Died leads at 40.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.